Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Ozone vs Dexamethasone Injection for Carpal Tunnel Syndrome
NCT06133712Recruiting
- Sponsor
- Tanta University
- Start
- Nov 2023
- Primary completion
- Dec 2025
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexmedetomidine and medical ozonated water in carpal tunnel syndrome (CTS) (3 arms), sponsored by Tanta University. Primary endpoint: Analgesic efficacy and functional status improvement at 24 weeks. Started Nov 2023; status: recruiting.
02
Drugs
dexmedetomidinemedical ozonated water
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT06133712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06133712.